Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo

Cancer Chemotherapy and Pharmacology

Volumn 58, Issue 1, 2006, Pages 24-34

  Tao, Lei ^a   Zhou, Liang ^a   Zheng, Luying ^b   Yao, Min ^c  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI CANCER INSTITUTE   (China)

Author keywords

Angiogenesis; Apoptosis; EIF; Elemene; Laryngeal squamous cell carcinoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BASIC FIBROBLAST GROWTH FACTOR; CASPASE 3; CISPLATIN; DOCETAXEL; ELEMENE; GEMCITABINE; INITIATION FACTOR 4E; INITIATION FACTOR 4G; PACLITAXEL; TERPENE DERIVATIVE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; FLOW CYTOMETRY; HEP 2 CELL; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LARYNX CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; WESTERN BLOTTING;

EID: 33645990875     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-005-0137-x     Document Type: Article

References (49)

1. Colasanto JM, Haffty BG, Wilson LD (2004) Evaluation of local recurrence and second malignancy in patients with T1 and T2 squamous cell carcinoma of the larynx. Cancer J 10:61-66
2. Moyer JS, Wolf GT, Bradford CR (2004) Current thoughts on the role of chemotherapy and radiation in advanced head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 12:82-87
3. Weise JB, Maune S, Gorogh T, Kabelitz D, Arnold N, Pfisterer J, Hilpert F, Heiser A (2004) A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC. Auris Nasus Larynx 31:149-153
4. Kroep JR, Peters GJ, van Moorsel CJ, Catik A, Vermorken JB, Pinedo HM, van Groeningen CJ (1999) Gemcitabine-cisplatin: a schedule finding study. Ann Oncol 10:1503-1510
5. Hitt R, Jimeno A, Millan JM, Castellano D, Cortes-Funes H (2004) Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck. Cancer 101:768-775
6. Zheng S, Yang H, Zhang S, Wang X, Yu L, Lu J, Li J (1998) Initial study on naturally occurring products from traditional Chinese herbs and vegetables for chemoprevention. J Cell Biochem 67:106-112
7. Chen SL, You J, Wang GJ (2001) Supercritical fluid extraction of beta-elemene under lower pressure. Se Pu 19:179-181
8. Zheng S, Yang H, Zhang S, Wang X, Yu L, Lu J, Li J (1997) Initial study on naturally occurring products from traditional Chinese herbs and vegetables for chemoprevention. J Cell Biochem Suppl 27:106-112
9. Yang H, Wang X, Yu L (1996) The antitumor activity of elemene is associated with apoptosis. Zhonghua Zhong Liu Za Zhi 18:169-172
10. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR, Martin SJ (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144:281-292
11. Yang XH, Sladek TL, Liu X, Butler BR, Froelich CJ, Thor AD (2001) Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res 61:348-354
12. Gupta S (2001) Molecular steps of death receptor and mitochondrial pathways of apoptosis. Life Sci 69:2957-2964
13. Clemens MJ, Bushell M, Jeffrey IW, Pain VM, Morley SJ (2000) Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ 7:603-615
14. De Benedetti A, Harris AL (1999) eIF4E expression in tumors: its possible role in progression of malignancies. Int J Biochem Cell Bio 31:59-72
15. Fukuchi-Shimogori T, Ishii I, Kashiwagi K, Mashiba H, Ekimoto H, Igarashi K (1997) Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res 57:5041-5044
16. McKendrick L, Pain VM, Morley SJ. Translation initiation factor 4E (1999) Int J Biochem Cell Bio 31:31-35
17. Zhang K, Chew M, Yang EB, Wong KP, Mack P (2001) Modulation of cisplatin cytotoxicity and cisplatin-induced DNA interstrand cross-links by regulation of glutathione related mechanisms. Mol Pharmacol 59:837-843
18. Evens AM, Prachand S, Shi B, Paniaqua M, Gordon LI, Gartenhaus RB (2004) Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependent. Clin Cancer Res 10:1481-1491
19. Muzio M, Salvesen GS, Dixit VM (1997) FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens. J Biol Chem 272:2952-2956
20. Zhou L, Tao L, Zheng LY, Gao YP (2003) The expression of proto-oncogene eIF4E in laryngeal squamous cell carcinoma. Laryngoscope 113:1238-1243
21. Nanda GS, Sun FX, Hofmann GA, Hoffman RM, Dev SB (1998) Electroporation therapy of human larynx tumors HEp-2 implanted in nude mice. Anticancer Res 18:999-1004
22. Zhang K, Chow PK (2004) The effect of megestrol acetate on growth of HepG2 cells in vitro and in vivo. Clin Cancer Res 10:5226-5232
23. Pavelic Z, Pavelic K, Cater C, Pavelic L (1992) Heterogeneity of c-myc expression in histologically similar infiltrating ductal carcinomas of the breast. J Cancer Res Clin Oncol 118:16-22
24. Gong W, Wang L, Yao JC, Ajani JA, Wei D, Aldape KD, Xie K, Sawaya R, Huang S (2005) Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin Cancer Res 11:1386-1393
25. Baskota DK, Prasad R, Sinha BK, Amatya RC, Bhattarai H, Guragain RP (2004) Outcome of surgical management of laryngeal carcinoma: a 5-year experience. Acta Otolaryngol 124:739-743
26. Jazirehi AR, Bonavida B (2005) Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention. Oncogene 24:2121-2143
27. Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, Wasserman T, Byhardt R (2005) Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. J Clin Oncol 23:2145-2154
28. Douer D, Tallman MS (2005) Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. J Clin Oncol 23:2396-2410
29. Hu J, Jin W, Yang PM (2004) Reversal of resistance to adriamycin in human breast cancer cell line MCF-7/ADM by beta-elemene. Zhonghua Zhong Liu Za Zhi 26:268-270
30. Zhou HY, Shen JK, Hou JS, Qiu YM, Luo QZ (2003) Experimental study on apoptosis induced by elemene in glioma cells. Ai Zheng 22:959-963
31. Bier H, Bergler W, Mickisch G, Wesch H, Ganzer U (1990) Establishment and characterization of cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79. Acta Otolaryngol 110:466-473
32. Engbers-Buijtenhuijs P, Kamphuis M, van der Sluijs Veer G, Haanen C, Pool AA, Feijen J, Vermes I (2005) A novel time resolved fluorometric assay of anoikis using Europium-labelled Annexin V in cultured adherent cells. Apoptosis 10:429-437
33. Pulkkinen JO, Elomaa L, Joensuu H, Martikainen P, Servomaa K, Grenman R (1996) Paclitaxel-induced apoptotic changes followed by time-lapse video microscopy in cell lines established from head and neck cancer. J Cancer Res Clin Oncol 122:214-218
34. Fujita E, Egashira J, Urase K, Kuitda K, Momoi T (2001) Caspase-9 processing by caspase-3 via a feedback amplification loop in vivo. Cell Death Differ 8:335-344
35. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA (2002) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43
36. Wang X, Zelenski NG, Yang J, Sakai J, Brown MS, Goldstein JL (1996) Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J 15:1012-1020
37. Liu B, Hannun YA (1997) Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J Biol Chem 272:16281-16287
38. Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, Rosen A (1996) Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principal of apoptotic death. J Exp Med 183:1957-1964
39. Liu L, Simon MC (2004) Regulation of transcription and translation by hypoxia. Cancer Biol Ther 3:492-427
40. von Der Haar T, Ball PD, McCarthy JE (2000) Stabilization of eukaryotic initiation factor 4E binding to the mRNA 5′-Cap by domains of eIF4G. J Biol Chem 275:30551-30555
41. Scheper GC, Proud CG (2002) Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation? Eur J Biochem 269:5350-5359
42. Prevot D, Darlix JL, Ohlmann T (2003) Conducting the initiation of protein synthesis: the role of eIF4G. Biol Cell 95:141-156
43. Tee AR, Proud CG (2002) Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif. Mol Cell Biol 22:1674-1683
44. Bushell M, McKendrick L, Janicke RU, Clemens MJ, Morley SJ (1999) Caspase-3 is necessary and sufficient for cleavage of protein synthesis eukaryotic initiation factor 4G during apoptosis. FEBS Lett 451:332-336
45. Sivan HK, Naomi LS, Dan G, Adi K (2000) A novel form of DAP5 protein accumulates in apoptotic cells as a result of caspase cleavage and internal ribosome entry site-mediated translation. Mol Cell Biol 20:496-506
46. Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF (1999) Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 5:1041-1056
47. Lund EL, Thorsen C, Pedersen MW, Junker N, Kristjansen PE (2000) Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro. Clin Cancer Res 6:4287-4291
48. Pignataro L, Carboni N, Midolo V, Bertolini F, Buffa R, Cesana BM, Neri A, Viale G, Pruneri G (2001) Clinical relevance of microvessel density in laryngeal squamous cell carcinomas. Int J Cancer 92:666-670
49. Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, Bucana CD, Hicklin DJ, Ellis LM (2000) Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer 89:488-499